Skip to main content
. 2014 Jun 30;9:150. doi: 10.1186/1748-717X-9-150

Figure 8.

Figure 8

“Effective” survival curve. An effective survival curve was established for radioresistant HT-1080 and Hs913T cell lines, in the context of fractionated radiotherapy, 2 Gy per fraction, delivered once daily for 25 days, with presence of NBTXR3 nanoparticles (400 μM), and compared with radiotherapy alone control (arrow indicate the BED).